This study reports the clinical, haematological and immunophenotypic f
eatures of a series of 25 patients with clonal expansions of large gra
nular lymphocytes (LGL)/NK-associated (NKa) cells. These showed a male
predominance (16:9) with a median age of 67 (range 38-91) years; four
had a documented history of rheumatoid arthritis, a further 18 had di
verse clinical disorders, and the remaining three were clinically well
. Mild anaemia was found in approximately half the patients and a lymp
hocytosis (seen in approximately 70% of the cases) was usually modest
(< 10.0 x 10(9)/l). Neutropenia was the most frequently observed featu
re, and this was typically persistent in nature. Serum studies reveale
d few consistent features although positive rheumatoid factor and incr
eased soluble CD8 levels were noted in 67% and 87% of those cases test
ed. Phenotypically, all cases were CD2(+)CD3(+)CD8(+) and expressed me
mbrane TCR alpha beta chains; most (17/22) were additionally CD5(+) an
d (19/22) CD7(+). The staining intensities of CD5 and CD7 antigens wer
e however lower than that of normal CD4(+) and CD8(+) blood lymphocyte
s. Expression of NKa antigens was variable although 16/22 cases were C
D16(+)CD56(-) and 19/22 were CD57(+). Clonal CD3(+)CD8(+) LGL/NKa expa
nsions with a CD16(+)CD56(+) composite phenotype were not seen in this
patient series. Analyses of 'activation' antigens showed a consistent
lack of CD25 expression by CD3(+) cells, but increased CD3/Ia co-expr
ession was found in a high proportion (19/25) of cases. Studies of CD4
5R isoform expression by CD8(+) LGL/NKa cell fractions revealed a cons
istent CD45RA(+)RO(-) profile for all cases tested. It is suggested th
at the clinical and cellular findings in these patients raise the dist
inct possibility that most of these clonal LGL/NKa disorders have a ch
ronic reactive rather than neoplastic aetiology.